CEO, Tempus ONE

Eric Lefkofsky’s Tempus Garners $200M to Bring Customized Medicine to the Latest Diseases

Ostensibly, Tempus seems to be an AI-actuated customized medicine agency that infuses a lot of technology and data into diagnosis. Eric Lefkofsky retaliates the feelings